Selvita Group reports over 109% increase in revenues for H1 2021

KRAKOW, Poland, Sept. 22, 2021 /PRNewswire/ — Selvita (WSE: SLV) one of the largest preclinical contract research organizations in Europe, continues its dynamic development in Poland and abroad.
Following the acquisition of Fidelta, Selvita Group achieved…

Click here to view the original article.